Noncommunicable Diseases
Recent clinical, regulatory, research and industry developments relating to this disease.
Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases.
Aging and "Age-Related" Diseases - What Is the Relation?
Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity.
Research HighlightsViewHide
- 2025-10-20Kaposi's Sarcoma: A Non-Communicable Outcome Mainly Prompted by Communicable Diseases in Sub-Saharan Africa.Mamimandjiami AI · 2025
- 2025-10-20ResearchKaposi's Sarcoma: A Non-Communicable Outcome Mainly Prompted by Communicable Diseases in Sub-Saharan Africa.Mamimandjiami AI · 2025
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Noncommunicable Diseases19
- COVID-194
- Gastrointestinal Microbiome3
- Microbiota3
- Probiotics3
- Aging2
- Climate Change2
- Communicable Diseases2
Leading journals6
- Nutrients3
- BMJ open2
- Frontiers in public health2
- Lancet (London, England)2
- Redox biology2
- Aging and disease1
Leading researchers8
- Baatiema L2
- Cuadrado A2
- Dinkova-Kostova AT2
- Grochot-Przeczek A2
- Levonen AL2
- Liu Y2
- López MG2
- Rojo AI2
Affiliations (unnormalised)6
- School of Public Health4
- A.I. Virtanen Institute for Molecular Sciences2
- Jacqui Wood Cancer Centre2
- Jagiellonian University2
- Medical College2
- School of Medicine2
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Noncommunicable diseases are a broad group of conditions that are typically non-infectious and do not spread from one person to another. The supplied grounding identifies the major categories as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes mellitus. They are described as a major and rising global burden of disease.
The grounding supports a multifactorial origin rather than a single cause. Reported contributors include westernized diet, environmental endocrine-disrupting chemicals, micro- and nanoplastics, urbanization-related lifestyle and environmental changes, and altered gut microbiota. The literature also links aging, loneliness, oxidative stress, and climate change to the broader noncommunicable disease burden.
The supplied reviews describe noncommunicable diseases as sharing inflammatory and immune dysfunction features, often alongside malnutrition-related physiopathology. Gut microbiota dysbiosis is presented as a bridge between external exposures and host metabolic and immune homeostasis, with oxidative stress and oxidation-reduction imbalance also implicated. NF-E2-related factor 2 is co-studied in this context, consistent with a role in redox biology.
Risk is increased by westernized dietary patterns, urbanization-associated lifestyle changes, pollution and hygiene-related environmental shifts, and exposure to endocrine-disrupting chemicals or micro- and nanoplastics. The grounding also identifies aging, loneliness, and climate change as relevant co-studied factors. Reduced physical activity and other unhealthy lifestyles are noted as worsening risk in the context of social distancing and quarantine restrictions.
The supplied grounding supports prevention and control approaches centered on lifestyle and environmental modification rather than a single disease-specific therapy. Diet is highlighted as a major modulator of immune-microbiota crosstalk, with Mediterranean-style nutritional approaches discussed as potentially beneficial compared with westernized diets. The literature also mentions therapy and drug therapy at a broad level, but does not provide a unified standard pharmacologic treatment for all noncommunicable diseases.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Diseases which are typically non-infectious in origin and do not transmit from an affected individual to others. The four main types of noncommunicable diseases are CARDIOVASCULAR DISEASES (e.g., heart attacks and stroke), CANCER, chronic respiratory diseases (e.g., CHRONIC OBSTRUCTIVE PULMONARY DISEASE and ASTHMA) and DIABETES MELLITUS.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.